It is straight forward really,
NNZ 2591 for RETT and Fragile X world wide is owned by ACADIA and pay royalties to Neuren.
NNZ2591 used for other diseases such as THE CURRENT 4 TRIALS NEU are doing will be owned exclusively by NEU.
BP van take over Neuren and have world rights to NNZ 2591 and recieve royalties from ACADIA for Rett Syndrome/ Daybue sales and fragile X when that eventuates.
It is straight forward really,NNZ 2591 for RETT and Fragile X...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.70 |
Change
0.520(2.71%) |
Mkt cap ! $2.515B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.84 | $19.28 | $5.675M | 288.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1531 | $19.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 557 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.70 |
Change
0.520 ( 2.59 %) |
||||
| Open | High | Low | Volume | ||
| $19.50 | $19.84 | $19.28 | 87628 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| NEU (ASX) Chart |